A phase 2 study of 16α-[18F]-fluoro-17β-estradiol positron emission tomography (FES-PET) as a marker of hormone sensitivity in metastatic breast cancer (MBC).

Purpose: 16α-[(18)F]-fluoro-17β-estradiol positron emission tomography (FES-PET) quantifies estrogen receptor (ER) expression in tumors and may provide diagnostic benefit.Procedures: Women with newly diagnosed metastatic breast cancer (MBC) from an ER-positive primary tumor were imaged before starti...

Descripción completa

Detalles Bibliográficos

Publicado en:	Molecular Imaging & Biology Vol. 16; no. 3; pp. 431 - 441
Autores principales:	Peterson, Lanell M, Kurland, Brenda F, Schubert, Erin K, Link, Jeanne M, Gadi, V K, Specht, Jennifer M, Eary, Janet F, Porter, Peggy, Shankar, Lalitha K, Mankoff, David A, Linden, Hannah M
Formato:	clinical trial research Journal Article
Publicado:	Springer Nature Jun2014
Acceso en línea:	Ver este registro en EBSCOhost